Search for evidence goes on
Identifieur interne : 001C16 ( Main/Exploration ); précédent : 001C15; suivant : 001C17Search for evidence goes on
Auteurs : Deborah Cohen [Royaume-Uni]Source :
- BMJ [ 0959-8138 ] ; 2012.
English descriptors
- Teeft :
- Acute influenza, Adverse events, Advisory committee, Antibody response, Antiviral, Antiviral agents, Antiviral medications, Clinical study reports, Cochrane, Cochrane collaboration, Cochrane group, Cochrane review, Cochrane reviewers, Complication, Critical care, Different approaches, Disease control, Drug approval process, Evidence base, Full study reports, Full trial data, Healthy adults, Hospital admissions, Immunization practices, Individual patient data, Influenza, January, Oseltamivir, Oseltamivir treatment, Oseltamivir trials, Other sources, Pandemic, Pandemic influenza, Press release, Prophylaxis, Public domain, Regulator, Regulatory documents, Rene snacken, Roche, Serious complications, Tract complications, Treatment trials, Trial data, Trial results.
Abstract
Oseltamivir (Tamiflu) is a multibillion pound success for the Swiss drug manufacturer Roche, with profits rocketing during the pandemic influenza of 2010. In the UK, general practitioners can now prescribe it to anyone with flu and the drug is the mainstay of influenza treatment in critical care. But how has this happened to a drug whose effectiveness is not backed up by publicly available evidence and whose manufacturer has broken successive pledges to make full study reports available? As a new Cochrane Collaboration meta-analysis is published, Deborah Cohen investigates
Url:
DOI: 10.1136/bmj.e458
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001F76
- to stream Istex, to step Curation: 001F76
- to stream Istex, to step Checkpoint: 000599
- to stream Main, to step Merge: 001C65
- to stream Main, to step Curation: 001C16
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Search for evidence goes on</title><author wicri:is="90%"><name sortKey="Cohen, Deborah" sort="Cohen, Deborah" uniqKey="Cohen D" first="Deborah" last="Cohen">Deborah Cohen</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:340089B570375075B648A3ED7661AA23943804E3</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1136/bmj.e458</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-718BNXPG-S/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001F76</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001F76</idno><idno type="wicri:Area/Istex/Curation">001F76</idno><idno type="wicri:Area/Istex/Checkpoint">000599</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000599</idno><idno type="wicri:doubleKey">0959-8138:2012:Cohen D:search:for:evidence</idno><idno type="wicri:Area/Main/Merge">001C65</idno><idno type="wicri:Area/Main/Curation">001C16</idno><idno type="wicri:Area/Main/Exploration">001C16</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Search for evidence goes on</title><author wicri:is="90%"><name sortKey="Cohen, Deborah" sort="Cohen, Deborah" uniqKey="Cohen D" first="Deborah" last="Cohen">Deborah Cohen</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>1 BMJ, London WC1H 9JR</wicri:regionArea><wicri:noRegion>London WC1H 9JR</wicri:noRegion></affiliation><affiliation></affiliation><affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="ISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2012">2012</date><biblScope unit="volume">344</biblScope></imprint><idno type="ISSN">0959-8138</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0959-8138</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Acute influenza</term><term>Adverse events</term><term>Advisory committee</term><term>Antibody response</term><term>Antiviral</term><term>Antiviral agents</term><term>Antiviral medications</term><term>Clinical study reports</term><term>Cochrane</term><term>Cochrane collaboration</term><term>Cochrane group</term><term>Cochrane review</term><term>Cochrane reviewers</term><term>Complication</term><term>Critical care</term><term>Different approaches</term><term>Disease control</term><term>Drug approval process</term><term>Evidence base</term><term>Full study reports</term><term>Full trial data</term><term>Healthy adults</term><term>Hospital admissions</term><term>Immunization practices</term><term>Individual patient data</term><term>Influenza</term><term>January</term><term>Oseltamivir</term><term>Oseltamivir treatment</term><term>Oseltamivir trials</term><term>Other sources</term><term>Pandemic</term><term>Pandemic influenza</term><term>Press release</term><term>Prophylaxis</term><term>Public domain</term><term>Regulator</term><term>Regulatory documents</term><term>Rene snacken</term><term>Roche</term><term>Serious complications</term><term>Tract complications</term><term>Treatment trials</term><term>Trial data</term><term>Trial results</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Oseltamivir (Tamiflu) is a multibillion pound success for the Swiss drug manufacturer Roche, with profits rocketing during the pandemic influenza of 2010. In the UK, general practitioners can now prescribe it to anyone with flu and the drug is the mainstay of influenza treatment in critical care. But how has this happened to a drug whose effectiveness is not backed up by publicly available evidence and whose manufacturer has broken successive pledges to make full study reports available? As a new Cochrane Collaboration meta-analysis is published, Deborah Cohen investigates</div></front></TEI><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Cohen, Deborah" sort="Cohen, Deborah" uniqKey="Cohen D" first="Deborah" last="Cohen">Deborah Cohen</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C16 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C16 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:340089B570375075B648A3ED7661AA23943804E3
|texte= Search for evidence goes on
}}
| This area was generated with Dilib version V0.6.34. |  |